Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Efendic

Showing results (51-60 of 223) with videos related to

Pageof 23
Sort By:
Diabetes Care|November 1, 1991
Effects of combination therapy with glyburide and insulin on serum lipid levels in NIDDM patients with secondary sulfonylurea failureS G Karlander, M K Gutniak, S Efendic
Pharmacology & Toxicology|July 1, 1988
Cholecystokinin (CCK)-33 stimulates insulin secretion from the perfused rat pancreas: studies on the structure-activity relationshipE Sandberg, B Ahrén, D Tendler, et al.
Acta Endocrinologica|June 1, 1979
Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjectsE Cerasi, S Efendic, C Thornqvist, et al.
Acta Physiologica Scandinavica|July 1, 1978
Dopaminergic control of antral gastrin and somatostatin releaseK Uvnäs-Wallensten, J M Lundberg, S Efendic
Acta Physiologica (Oxford, England)|January 4, 2008
Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugsS Efendic, M Alvarsson, K Brismar, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Low insulin response: a marker of prediabetesS Efendic, V Grill, R Luft, et al.
Diabetologia|November 1, 1981
Dose-kinetics of pancreatic glucagon responses to arginine and glucose in subjects with normal and impaired pancreatic B cell functionR Assan, S Efendic, R Luft, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1996
Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1-year follow-upP Clauson, S Karlander, L Steen, et al.
Journal of Internal Medicine|April 16, 2002
A rapid increase in beta-cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatmentL Kärvestedt, G Andersson, S Efendic, et al.
Endocrine|February 1, 1997
Truncated and full-length glucagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin releaseP L Brubaker, S Efendic, G R Greenberg
Pageof 23

Showing results (51-60 of 223) with videos related to

Sort By:
Pageof 23
Diabetes Care|November 1, 1991
Effects of combination therapy with glyburide and insulin on serum lipid levels in NIDDM patients with secondary sulfonylurea failureS G Karlander, M K Gutniak, S Efendic
Pharmacology & Toxicology|July 1, 1988
Cholecystokinin (CCK)-33 stimulates insulin secretion from the perfused rat pancreas: studies on the structure-activity relationshipE Sandberg, B Ahrén, D Tendler, et al.
Acta Endocrinologica|June 1, 1979
Effect of two sulphonylureas on the dose kinetics of glucose-induced insulin release in normal and diabetic subjectsE Cerasi, S Efendic, C Thornqvist, et al.
Acta Physiologica Scandinavica|July 1, 1978
Dopaminergic control of antral gastrin and somatostatin releaseK Uvnäs-Wallensten, J M Lundberg, S Efendic
Acta Physiologica (Oxford, England)|January 4, 2008
Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugsS Efendic, M Alvarsson, K Brismar, et al.
Advances in Experimental Medicine and Biology|January 1, 1988
Low insulin response: a marker of prediabetesS Efendic, V Grill, R Luft, et al.
Diabetologia|November 1, 1981
Dose-kinetics of pancreatic glucagon responses to arginine and glucose in subjects with normal and impaired pancreatic B cell functionR Assan, S Efendic, R Luft, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|May 1, 1996
Daytime glibenclamide and bedtime NPH insulin compared to intensive insulin treatment in secondary sulphonylurea failure: a 1-year follow-upP Clauson, S Karlander, L Steen, et al.
Journal of Internal Medicine|April 16, 2002
A rapid increase in beta-cell function by multiple insulin injections in type 2 diabetic patients is not further enhanced by prolonging treatmentL Kärvestedt, G Andersson, S Efendic, et al.
Endocrine|February 1, 1997
Truncated and full-length glucagon-like peptide-1 (GLP-1) differentially stimulate intestinal somatostatin releaseP L Brubaker, S Efendic, G R Greenberg
Pageof 23